Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria

Table 2 Study outcome of trial participants

Characteristics/Outcome	Group I	Group II	Group I and II
Characteristics/Outcome	600/750 mg ≥30 kg	300/375 mg 15 – 30 kg	All Participants
Number enrolled	208	238	446
Number completed	203	228	431
Withdrawal/loss to follow up	5(2.5%)	10(4.45)	15(3.5%)
Adequate Clinical and Parasitological Response (ACPR)
Day 28*	202(99.5%)	222(97.4%)	424(97.45%)
Parasite Clearance Time	40.1 hrs	42.4 hrs	41.3

ISSN: 1475-2875